PMC:7144273 / 47914-48106
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T430","span":{"begin":49,"end":66},"obj":"Body_part"},{"id":"T431","span":{"begin":61,"end":66},"obj":"Body_part"}],"attributes":[{"id":"A430","pred":"fma_id","subj":"T430","obj":"http://purl.org/sig/ont/fma/fma70573"},{"id":"A431","pred":"fma_id","subj":"T431","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Experimental group: 5×106 LV-DC vaccine or 1×108 cytotoxic T-cells as a single infusion via subcutaneous fluids or i.v. injection; may receive additional infusionsControl group: none specified"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T665","span":{"begin":59,"end":66},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T666","span":{"begin":70,"end":71},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Experimental group: 5×106 LV-DC vaccine or 1×108 cytotoxic T-cells as a single infusion via subcutaneous fluids or i.v. injection; may receive additional infusionsControl group: none specified"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T237","span":{"begin":13,"end":18},"obj":"Chemical"},{"id":"T238","span":{"begin":26,"end":28},"obj":"Chemical"},{"id":"T239","span":{"begin":171,"end":176},"obj":"Chemical"}],"attributes":[{"id":"A237","pred":"chebi_id","subj":"T237","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A238","pred":"chebi_id","subj":"T238","obj":"http://purl.obolibrary.org/obo/CHEBI_73579"},{"id":"A239","pred":"chebi_id","subj":"T239","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"Experimental group: 5×106 LV-DC vaccine or 1×108 cytotoxic T-cells as a single infusion via subcutaneous fluids or i.v. injection; may receive additional infusionsControl group: none specified"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T213","span":{"begin":20,"end":192},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Experimental group: 5×106 LV-DC vaccine or 1×108 cytotoxic T-cells as a single infusion via subcutaneous fluids or i.v. injection; may receive additional infusionsControl group: none specified"}